Sandoz launched Symjepi in January. Symjepi to Swiss pharma giant Novartis. Adamis and Sandoz, a division of Novartis. With the rising costs of healthcare in recent years, Adamis has been focusing on creating low-cost therapeutic alternatives in large markets in order to grow its business and to make treatments more affordable for more people. If you treasured this article and you also would like to obtain more info pertaining to buy viagra nicely visit our web-site.